215 related articles for article (PubMed ID: 1448490)
1. The CCK-A receptor antagonist, devazepide, blocks the anorectic action of CCK but not peripheral serotonin in rats.
Eberle-Wang K; Simansky KJ
Pharmacol Biochem Behav; 1992 Nov; 43(3):943-7. PubMed ID: 1448490
[TBL] [Abstract][Full Text] [Related]
2. Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329.
Cooper SJ; Dourish CT; Barber DJ
Br J Pharmacol; 1990 Jan; 99(1):65-70. PubMed ID: 2331576
[TBL] [Abstract][Full Text] [Related]
3. The effect of centrally administered CCK-receptor antagonists on food intake in rats.
Corp ES; Curcio M; Gibbs J; Smith GP
Physiol Behav; 1997 Jun; 61(6):823-7. PubMed ID: 9177553
[TBL] [Abstract][Full Text] [Related]
4. Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats.
Melville LD; Smith GP; Gibbs J
Pharmacol Biochem Behav; 1992 Nov; 43(3):975-7. PubMed ID: 1448494
[TBL] [Abstract][Full Text] [Related]
5. CCK(A) and 5-HT3 receptors interact in anorectic responses to amino acid deficiency.
Aja SM; Barrett JA; Gietzen DW
Pharmacol Biochem Behav; 1999 Mar; 62(3):487-91. PubMed ID: 10080241
[TBL] [Abstract][Full Text] [Related]
6. Devazepide attenuates dl-fenfluramine-induced suppression of gastric emptying but not food intake in the 17 h food-deprived rat.
Francis J; Dourish CT; Cooper SJ
Physiol Behav; 1997 Sep; 62(3):545-50. PubMed ID: 9272662
[TBL] [Abstract][Full Text] [Related]
7. Serotonin contracts the isolated rat pylorus via a 5-HT2-like receptor.
Eberle-Wang K; Braun BT; Simansky KJ
Am J Physiol; 1994 Jan; 266(1 Pt 2):R284-91. PubMed ID: 8304552
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin- and dexfenfluramine-induced anorexia compared using devazepide and c-fos expression in the rat brain.
Li BH; Rowland NE
Regul Pept; 1994 Mar; 50(3):223-33. PubMed ID: 8016407
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent effects of CCK and devazepide in male and female rats.
Salorio CF; Hammond PB; Schwartz GJ; McHugh PR; Moran TH
Physiol Behav; 1994 Oct; 56(4):645-8. PubMed ID: 7800726
[TBL] [Abstract][Full Text] [Related]
10. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
Brenner LA; Ritter RC
Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
[TBL] [Abstract][Full Text] [Related]
11. PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement.
Verbaeys I; León-Tamariz F; Buyse J; De Cuyper M; Pottel H; Van Boven M; Cokelaere M
Br J Pharmacol; 2007 Oct; 152(3):396-403. PubMed ID: 17618299
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding patterns in rats.
Grignaschi G; Mantelli B; Fracasso C; Anelli M; Caccia S; Samanin R
Br J Pharmacol; 1993 Jun; 109(2):491-4. PubMed ID: 8358548
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of central and peripheral anorectic effects of caerulein by L-364,718.
Leighton GE; Griesbacher T; Hill RG; Hughes J
Eur J Pharmacol; 1989 Feb; 161(2-3):255-8. PubMed ID: 2721558
[TBL] [Abstract][Full Text] [Related]
14. 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.
Ebenezer IS; Baldwin BA
Br J Pharmacol; 1995 Nov; 116(5):2371-4. PubMed ID: 8581271
[TBL] [Abstract][Full Text] [Related]
15. Effect of BIM-18216, a novel cholecystokinin receptor antagonist, on food intake reduction induced by cholecystokinin.
Laferrere B; Nguyen M; Bonhomme G; Legall A; Basdevant A; Guy-Grand B
Behav Neurosci; 1991 Oct; 105(5):707-11. PubMed ID: 1815620
[TBL] [Abstract][Full Text] [Related]
16. Role of cholecystokinin in the anorexia produced by duodenal delivery of glucose in rats.
Woltman T; Reidelberger R
Am J Physiol; 1996 Dec; 271(6 Pt 2):R1521-8. PubMed ID: 8997348
[TBL] [Abstract][Full Text] [Related]
17. Devazepide reverses the anorexic effect of simmondsin in the rat.
Cokelaere MM; Busselen P; Flo G; Daenens P; Decuypere E; Kühn E; Van Boven M
J Endocrinol; 1995 Dec; 147(3):473-7. PubMed ID: 8543917
[TBL] [Abstract][Full Text] [Related]
18. Intravenous infusion of CCKA-receptor antagonist increases food intake in rats.
Miesner J; Smith GP; Gibbs J; Tyrka A
Am J Physiol; 1992 Feb; 262(2 Pt 2):R216-9. PubMed ID: 1539728
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
[TBL] [Abstract][Full Text] [Related]
20. Lack of interaction between devazepide and 8-OH-DPAT-induced hyperphagia in the rat.
Francis J; Dourish CT; Cooper SJ
Physiol Behav; 1996 Nov; 60(5):1337-40. PubMed ID: 8916191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
